Last reviewed · How we verify
NCT04308551
Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease
NA trial testing Indobufen in Stable Coronary Heart Disease. Withdrawn.
30 December 2026
Quick facts
| Lead sponsor | Henan Institute of Cardiovascular Epidemiology |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Start date | 30 December 2024 |
| Primary completion | 30 December 2026 |
| Estimated completion | 30 December 2026 |
Drugs / interventions tested
Conditions studied
- Stable Coronary Heart Disease — all drugs for Stable Coronary Heart Disease →
Sponsor
Henan Institute of Cardiovascular Epidemiology
Who can join
Adults 18 to 85, any sex, with Stable Coronary Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effect of Indobufen and Aspirin on platelet aggregation and long term prognosis in patients with stable coronary heart disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04308551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Indobufen
Trials testing the same drug.
- NCT06451198 — IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome · Phase 4 · recruiting
- NCT03871517 — INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE · Phase 4 · completed
Other Henan Institute of Cardiovascular Epidemiology trials
Trials by the same sponsor.
- NCT07514624 — CRIC Combined With MFT for MFR in Patients With Incomplete Revascularization of CAD · NA · not yet recruiting
- NCT06820970 — CRIC Combined With MFT for Cardiovascular Adverse Events in Patients With Incomplete Revascularization of CAD · NA · recruiting
- NCT06769256 — Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden · Phase 4 · recruiting
- NCT07181356 — Effects of Long-term Remote Ischemic Preconditioning on Clinical Outcome in Patients With Acute Myocardial Infarction · NA · recruiting
- NCT06676137 — An Observational Study of Coronary Microvascular Disease of China · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04308551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henan Institute of Cardiovascular Epidemiology
- Last refreshed: 20 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04308551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing